InvestorsHub Logo

jbog

09/27/10 7:36 AM

#105121 RE: exwannabe #105120

exwannabe,

Are they going to go to the FDA with this or just EMA?

tia

genisi

09/27/10 8:14 AM

#105123 RE: exwannabe #105120

SGEN/SGN-35 pivotal trial in HL - even better than phase I!

genisi

10/11/10 3:43 PM

#106170 RE: exwannabe #105120

SGEN/vedotin (SGN-35) in ALCL :

http://www.marketwatch.com/story/seattle-genetics-and-millennium-announce-positive-top-line-brentuximab-vedotin-sgn-35-data-from-phase-ii-trial-in-relapsed-or-refractory-alcl-2010-10-11?reflink=MW_news_stmp

"...Eighty-six percent of patients in the trial achieved an objective response as assessed by an independent central review. Overall response rate, including both complete and partial remissions, is the primary endpoint of the study. The median duration of response has not yet been reached at a median follow up on study of approximately six months."